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Abstract Two tetrodotoxin-resistant voltage-gated sodium
channels, SNS/PN3 and SNS2/NaN, have been described
recently in small-diameter sensory neurones of the rat, and play
a key role in neuropathic pain. Using region-specific antibodies
raised against different peptide sequences of their K subunits, we
show by Western blot evidence for the presence of these channels
in human nerves and sensory ganglia. The expected fully mature
260 kDa component of SNS/PN3 was noted in all injured nerve
tissues obtained from adults; however, for SNS2/NaN, smaller
bands were found, most likely arising from protein degradation.
There was increased intensity of the SNS/PN3 260 kDa band in
nerves proximal to the site of injury, whereas it was decreased
distally, suggesting accumulation at sites of injury; all adult
patients had a positive Tinel’s sign at the site of nerve injury,
indicating mechanical hypersensitivity. Injured nerves from
human neonates showed similar results for both channels, but
neonate neuromas lacked the SNS2/NaN 180 kDa molecular
form, which was strongly present in adult neuromas. The
distribution of SNS/PN3 and SNS2/NaN sodium channels in
injured human nerves indicates that they represent targets for
novel analgesics, and could account for some differences in the
development of neuropathic pain in infants.
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1. Introduction
Subsets of sensory neurones express di¡erent sodium chan-
nels, which a¡ect their electrophysiological properties, and
may relate to their function in normal and pathophysiological
states [1,2]. Sodium currents, including tetrodotoxin-sensitive
(TTX-S) and TTX-resistant (TTX-R) currents, may contrib-
ute to ectopic generation of action potentials following nerve
injury [3]. As ectopic impulse activity may be related to symp-
toms, including pain phenomena, these sodium channels form
potential targets for novel analgesics in neuropathic pain.
The sodium channels are heterodimers composed of an K
subunit (260 kDa) and two smaller subunits, L1 and L2, which
can regulate the properties of the K subunit [4]. The sensory
neurone-speci¢c SNS/PN3 K subunit was initially identi¢ed as
a 6.5 kb transcript expressed selectively in rat dorsal root
ganglia (DRG) with a full-length cDNA clone encoding a
1957 amino acid protein that has 65% identity with the amino
acid sequence of rat cardiac TTX-insensitive sodium channel
[5,6]. In an in vitro transcription/translation system, a 220
kDa protein was generated [5].
There is increasing evidence that SNS/PN3 may play a key
role in nociception. A recent study has shown that SNS-null
mutant mice demonstrate pronounced analgesia to mechanical
noxious stimuli [7]. Antisense mRNA experiments have sug-
gested that SNS/PN3 but not SNS2/NaN [8,9], another TTX-
R sodium channel that is distributed within the DRG, is crit-
ical in animal models of neuropathic pain [10]. This evidence
is supported by our recent immunohistochemical studies of
the distribution of these two channels in injured human sen-
sory neurones [11]. However, little is known about the molec-
ular forms of these channels in humans. The present study
therefore examined the presence and molecular forms of
KSNS/PN3 and KSNS2/NaN in normal and damaged human
nerve preparations, using antibodies derived from rat peptide
sequences of these channels. Since accumulation of these
channels at sites of nerve injury may lead to ectopic impulse
activity and chronic pain phenomena [11], which we have
observed not to occur after nerve injury in the neonatal hu-
man and rat [12], we have also studied, for the ¢rst time,
injured nerves from human neonates.
2. Materials and methods
2.1. Tissue specimens
Nerves and DRG were collected from adult patients (n = 16, age
range 18^67 years) with spinal cord root avulsion injury, and damage
to the brachial plexus. These included three neuromas, ¢ve nerves
proximal to the site of injury, ¢ve nerves distal to the site of injury
and ¢ve avulsed DRG, all collected within a week after injury. Six
normal nerves were obtained from surgical limb amputations for non-
neurological conditions. Injured nerves were also obtained from ba-
bies with obstetric brachial plexus palsy undergoing nerve repair
(n = 5, age range: 3^4 months); the specimens included two neuromas,
three nerves proximal and three distal to site of injury. Surgical trim-
mings of three normal nerves used for grafting were available. The
tissues were snap frozen and stored at 370‡C. The removal of all
tissues was a necessary part of the surgical repair procedure, and their
use for the study was approved by the local Ethics Committee, and
the patients or parents.
2.2. Antisera
Two di¡erent KSNS/PN3 channel antibodies were used in this
study, an antibody, SNS poly 11, raised against amino acid residues
424^591 of the intracellular linker between domain I and domain II
(gift from Professor J. Wood, UCL), and antibody PN3 #20073,
raised against amino acid residues 1059^1077 of the intracellular
loop between domain II and domain III, obtained from Roche Bio-
sciences, Palo Alto, CA, USA. An SNS2/NaN antibody (#33948) was
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 1 6 6 - 2
*Corresponding author. Fax: (44)-181-383 3363/3364.
E-mail: p.anand@ic.ac.uk
FEBS 23312 3-2-00
FEBS 23312 FEBS Letters 467 (2000) 249^252
obtained from Roche Biosciences, Palo Alto, CA, USA. A monoclo-
nal antibody that reacts with the phosphorylated form of the 200 kDa
component of human neuro¢laments was also used (Dako, Cam-
bridge, UK, No. M 0762).
2.3. Extraction
Frozen tissue was ¢rst pulverised using a mortar and pestle pre-
cooled by liquid nitrogen. It was then homogenised with 20 strokes of
a mechanical Dounce homogeniser in ice-cold extraction bu¡er (phos-
phate-bu¡ered saline (PBS) containing 1% NP40, 0.5% sodium deox-
ycholate and 0.1% sodium dodecyl sulfate (SDS)) containing freshly
added protease inhibitors (5 mM PMSF, 2 mM benzamidine, 1 mM
iodoacetamide and 50 mg/ml aprotinin) and incubated on ice for 30
min. Homogenates were then spun at 5000Ug for 15 min. The pellet
was discarded and the supernatant was either used immediately or
stored at 370‡C. An aliquot of the supernatant was taken and total
protein measured using a Bradford dye-binding protein assay accord-
ing to the manufacturer’s instructions (Bio-Rad laboratories, Hert-
fordshire, UK). Homogenates containing equal amounts of protein
(approximately 20 Wg) were combined with SDS sample bu¡er and
incubated at 100‡C for 10 min before loading on a 6% SDS^polyac-
rylamide gel [13]. After electrophoresis, proteins were transferred to
nitrocellulose membranes (Hybond Super, Amersham Life Science,
Buckinghamshire, UK) using a semi-dry transblotter at a constant
200 mA for 16 h at 4‡C. Protein bands were visualised by staining
membranes with 0.1% (w/v) Ponceau S in 1% (v/v) acetic acid, and if
necessary, strips were cut out. Excess dye was removed by several
washes with PBS wash bu¡er.
2.4. Immunoblotting
Non-speci¢c binding sites were blocked by incubating the strips in
5% (w/v) non-fat dry milk in a solution of PBS containing 0.1% (v/v)
Tween 20 for 1 h. Strips were then incubated for a further 2 h with
primary antibody. For competition studies, antibodies was pre-incu-
bated by the addition of 10 Wg of corresponding immunogen for 1 h at
room temperature. After washing, the blots were incubated with sec-
ondary antibody-biotin complexes (Vector Laboratories, Peterbor-
ough, UK) for a further 45 min. A pre-formed complex between
avidin and biotinylated horseradish peroxidase (Vector Laboratories,
Peterborough, UK) was ¢nally added for a further 45 min. Immuno-
reactive bands were visualised on Hyper¢lm after treatment of the
blots with ECL-plus Western blotting detection system (Amersham
Life Science, Buckinghamshire, UK).
3. Results
3.1. SNS/PN3
A 260 kDa band, with an additional 220 kDa band in some
preparations, was found to react with the antibody SNS poly
11. Fig. 1 shows the Western blot pro¢le using the antibody
SNS poly 11 in avulsed cervical DRG and normal nerve prep-
arations. The predicted 260 kDa form is clearly detectable,
and a smaller 220 kDa band was seen in some preparations,
similar to previous reports in the rat [5]. The intensity of both
of these SNS/PN3-like bands was virtually abolished when
primary antibody was pre-incubated with excess SNS/PN3
fusion protein (Fig. 2). With antibody PN3 #20073, intense
SNS/PN3 immunoreactivity was detected at 220 kDa but not
260 kDa in all the preparations studied. This immunoreactiv-
ity was signi¢cantly diminished by pre-incubation with cog-
nate antigen (data not shown).
SNS/PN3-like immunoreactivity was detected in all the
avulsed DRG, and nerves proximal to the injury site. There
was no 260 kDa band in two out of ¢ve distal to injury adult
nerve extracts, and this was reduced where detected. The 260
kDa SNS/PN3-like band was also found in most of the neo-
natal extracts examined, which in some specimens was also
accompanied by a 220 kDa band (Fig. 3a). There was a sim-
ilar decrease in the 260 kDa band in damaged infant nerve
preparations distal to the site of injury. In these distal prep-
arations, neuro¢lament 200 kDa protein was also reduced, as
expected (Fig. 3b). The 260 kDa band was not detected in
either normal human muscle or spinal cord extracts that
were examined (data not shown).
3.2. SNS2/NaN
In all three adult neuroma preparations, a strong 180 kDa
band was detected with the SNS2/NaN antibody, and some-
Fig. 1. Western blot analysis of adult human nerve homogenates.
Blots were probed using the anti-SNS/PN3 antibody SNS poly 11
and visualised by enhanced chemiluminescence. Lanes 1^3, avulsed
sensory ganglia from three di¡erent patients; lane 4, normal nerve.
The positions of the SNS-immunoreactive bands are indicated by
arrow heads.
Fig. 2. Speci¢city of Western blot with anti-SNS antibody SNS poly
11. Blots were probed using the anti-SNS antibody SNS poly 11 in
the absence (lane 1) or presence of 10 mg of SNS/PN3 fusion pro-
tein (lane 2), and visualised by enhanced chemiluminescence. The
positions of the SNS/PN3-immunoreactive bands are indicated by
arrow heads.
Fig. 3. Western blot analysis of neonate human nerve homogenates.
Blots were probed using the anti-SNS antibody SNS poly 11 (a), or
probed for neuro¢laments (b), and visualised by enhanced chemilu-
minescence: lane 1, neuroma; lane 2, damaged nerve distal to site
of injury; lane 3, damaged nerve proximal to site of injury.
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times seen with a fainter 190 kDa band (Fig. 4, lane 4). These
molecular weight forms of this channel were also detected, but
as fainter bands, in 2/4 proximal nerve preparations, but were
not detected in undamaged nerve preparations (including nor-
mal nerves from the same patient), or in ¢ve avulsed DRG.
The 180 kDa band was not detected in any of the baby nerve
preparations studied (Fig. 4, lanes 1^3). This was con¢rmed
on ¢ve other separate experiments, even when more antigen
was loaded on the gels (data not shown). However, smaller
140 kDa and 90 kDa were found in nearly all the nerve prep-
arations studied. After competition with cold peptide, the
main bands disappeared (180, 140 and 90 kDa, data not
shown). The three major PN5-reacting proteins mentioned
above were not detected in one human spinal cord and one
human skeletal muscle extract preparation that were also
studied.
4. Discussion
We have demonstrated, for the ¢rst time, the presence of
di¡erent protein molecular forms of SNS/PN3 and SNS2/
NaN in human nerve extracts. The expected 260 kDa glyco-
protein representing the fully mature K subunit of SNS/PN3
was easily detectable in all the avulsed sensory ganglia, neuro-
mas and nerves proximal to injury. It was also present in most
but not all normal human nerve specimens that were studied.
The protein was not detected in human muscle or spinal cord
extracts, in accord with the tissue speci¢city of this channel
[5,6].
The smaller 220 kDa SNS/PN3-like band in our study may
correspond to the smallest KSNS/PN3 form of similar size
that was described in an in vitro translation expression system
by others [5]. Alternatively, it is possible that the 220 kDa
SNS/PN3-like form represents a product of an alternate
spliced form. The larger 260 kDa and 240 kDa bands may
correspond to di¡erent post-translated glycosylated products,
as has been described for the developmental forebrain sodium
channels [14].
In specimens in which both proximal and distal nerve had
been resected from the site of injury, the intensity of the 260
kDa SNS/PN3-like band always appeared higher in the prox-
imal stump compared to the distal stump. As the patients
from whom injured peripheral nerves were collected also
had spinal cord root avulsions and pain arising from de-a¡er-
entation of the spinal cord, it is not possible to correlate
changes in sodium channels with pain phenomena in any
simple manner; however, they all had a positive Tinel’s sign
at the site of nerve injury, indicating mechanical hypersensi-
tivity. SNS/PN3 is known to be synthesised in the DRG and
transported to the site of nerve injury, as demonstrated in an
animal model [15], where its increased density may contribute
to ectopic impulse generation and pain phenomena, including
hypersensitivity. After axotomy, rat DRG neurones down-reg-
ulate SNS/PN3 transcripts, but there is, nevertheless, accumu-
lation of the sodium channels at the point of nerve injury,
indicating translocation of sodium channels from the cell
body to the axon [15]. Peripheral in£ammatory processes
may enhance such accumulation, as in£ammatory modulators
up-regulate TTX-R current [16^18] and KSNS/PN3 transcripts
[18] in small-sized DRG neurones.
We failed to detect the fully glycosylated 260 kDa K unit of
SNS2/NaN, which we could readily demonstrate for SNS/
PN3. Instead, smaller immunoreactive bands were consis-
tently detected in all specimens studied. This might suggest
that the former is less abundant, or may be more rapidly
broken down, either by endogenous proteases or during our
extraction process. Proteolytic proteins of 90 kDa and 140
kDa have been described for sodium channels present in skel-
etal muscle [19] and in cultured foetal neurones [20]. The
presence of the SNS2/NaN 180 kDa band in adult but not
neonate neuromas is of interest, as we have previously ob-
served that neonatal human and rats fail to develop the clas-
sical pain syndromes after peripheral nerve injury [12]. It may
be hypothesised that full expression and clustering of sodium
channels is necessary for the development of pain phenomena;
in support, nerve conduction velocity, which is dependent on
clustering of sodium channels at nodes of Ranvier, achieves
adult values at the age of 2^3 years in humans, when nerve
injury does lead to chronic pain syndromes.
In summary, antibodies raised against rat KSNS/PN3 and
SNS2/NaN reacted speci¢cally with these sodium channel-like
proteins in peripheral nerve specimens in man. Only the ma-
ture KSNS/PN3 260 kDa band was found in abundance in all
avulsed DRGs, nerves proximal to injury, and neuromas.
Although further studies are thus clearly required to elucidate
the function of this channel in human pain states, our work
indicates that it may be a useful target for novel analgesics in
neuropathic pain.
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